Physicians integrate GLP-1 treatments with nutritional counseling, lifestyle modifications, and behavioral supportall essential for long-term success
CMS may update the list of covered drugs and their National Drug Codes (NDCs) over the course of the program, so it is worth checking back for updates
It contains FDA-approved Semaglutide base, a glucagon-like peptide 1 (GLP-1) receptor agonist
It helps improve products' nutritional profile, making scFOS a popular ingredient in foods and beverages, aligning with the growing consumer preference for healthier and more functional food options
Mathiesen ER, Alibegovic AC, Corcoy R et al (2023) Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial
Blocks DHT, a hormone that damages follicles